GCTCX
Price
$47.01
Change
-$0.24 (-0.51%)
Updated
Sep 25 closing price
Net Assets
4.36B
VFFSX
Price
$324.07
Change
-$1.63 (-0.50%)
Updated
Sep 25 closing price
Net Assets
1.37T
Interact to see
Advertisement

GCTCX vs VFFSX

Header iconGCTCX vs VFFSX Comparison
Open Charts GCTCX vs VFFSXBanner chart's image
Goldman Sachs US Tax-Managed Eq C
Price$47.01
Change-$0.24 (-0.51%)
VolumeN/A
Net Assets4.36B
Vanguard 500 Index Institutional Select
Price$324.07
Change-$1.63 (-0.50%)
VolumeN/A
Net Assets1.37T
GCTCX vs VFFSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCTCX vs. VFFSX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTCX is a Hold and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.37T vs. GCTCX (4.36B). VFFSX pays higher dividends than GCTCX: VFFSX (1.18) vs GCTCX (0.00). GCTCX was incepted earlier than VFFSX: GCTCX (26 years) vs VFFSX (9 years). GCTCX (1.80) is less costly to investors than VFFSX (0.01). GCTCX is a more actively managed with annual turnover of: 96.00 vs. VFFSX (2.00). GCTCX has a lower initial minimum investment than VFFSX: GCTCX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 16.07 vs. GCTCX (13.01). VFFSX return over 5 years is better than : 101.38 vs. GCTCX (92.07).
GCTCXVFFSXGCTCX / VFFSX
Total Expense Ratio1.760.0117,600%
Annual Report Gross Expense Ratio1.800.0118,000%
Fund Existence26 years9 years-
Gain YTD11.02013.21483%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.36B1.37T0%
Annual Yield % from dividends0.001.18-
Returns for 1 year13.0116.0781%
Returns for 3 years77.0381.7294%
Returns for 5 years92.07101.3891%
Returns for 10 years211.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVTX24.600.19
+0.80%
Travere Therapeutics
DALN16.51N/A
N/A
DallasNews Corp
ICLR162.53-4.96
-2.96%
ICON plc
TTNP4.03-0.25
-5.90%
Titan Pharmaceuticals
DAVA8.80-0.58
-6.18%
Endava plc